Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets

March 5th, 2020|Portfolio News|

Camel-IDS appoints Ruggero Della Bitta MD, PhD, as Chief Medical Officer

October 8th, 2019|Portfolio News|

Camel-IDS appoints Thomas Ramdahl as Independent Director

May 17th, 2019|Portfolio News|

Syndesi Therapeutics announces initiation of Phase I study of novel SV2A modulator

May 8th, 2019|Portfolio News|

Confo Therapeutics raises €30 million in Series A financing

May 7th, 2019|Portfolio News|

Confo Therapeutics enters into drug discovery collaboration with Roche

December 19th, 2017|Portfolio News|

OCTIMET Oncology NV awarded €1.12 million grant from VLAIO

November 7th, 2017|Portfolio News|

Confo Therapeutics enters into drug discovery collaboration with Lundbeck

September 26th, 2017|Portfolio News|

Octimet: Dosing of First Patient with investigational agent OMO-1

August 25th, 2017|Portfolio News|

Oxular Appoints David Fellows as Chairman of the Board

January 11th, 2017|Portfolio News|

Confo Therapeutics appoints Dr. Cedric Ververken as Chief Executive Officer

September 6th, 2016|Portfolio News|

Precision Ocular Ltd Completes £15.5 million Series A Financing V-Bio Ventures joins investment syndicate

July 19th, 2016|Portfolio News|

Confo Therapeutics appoints Dr Christel Menet as Chief Scientific Officer

May 10th, 2016|Portfolio News|